Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

16.93

-0.04 (-0.24%)

At close: Jul 17, 2026, 4:00 PM EDT

16.96

+0.03 (0.18%)

After-hours: Jul 17, 2026, 4:10 PM EDT

Theravance Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	109.78	107.46	64.38	57.42	51.35	55.31
Revenue Growth (YoY)	68.20%	66.92%	12.12%	11.84%	-7.17%	-23.03%
Gross Profit	109.78	107.46	64.38	57.42	51.35	55.31
Selling, General & Admin	73	73.65	69.17	70.1	67.07	99.3
Research & Development	31.79	37.41	37.64	40.62	63.39	193.66
Other Operating Expenses	3.63	-	4.51	2.74	12.84	20.14
Total Operating Expenses	108.43	111.07	111.33	113.46	143.3	313.1
Operating Income	1.35	-3.6	-46.95	-56.04	-91.96	-257.78
Interest Income	12.25	10.17	4.88	9.12	8.55	1.11
Interest Expense	-1.82	-2.46	-2.55	-2.35	-6.37	-8.55
Other Non-Operating Income (Expense)	-	125.14	-	-	-3.03	-
Total Non-Operating Income (Expense)	10.43	132.85	2.34	6.77	-0.86	-7.44
Pretax Income	-6.47	129.25	-44.61	-49.27	-92.82	-265.22
Provision for Income Taxes	-8.04	-	-	-	-	-0.15
Net Income	1.57	129.25	-44.61	-49.27	-92.82	-265.07
Earnings From Discontinued Operations	-	-	-	-	964.96	65.65
Net Income to Common	-4.93	129.25	-44.61	-55.19	872.14	-199.43
Shares Outstanding (Basic)	51	50	49	55	74	69
Shares Outstanding (Diluted)	52	52	49	55	74	69
Shares Change (YoY)	4.90%	5.45%	-11.67%	-24.85%	5.95%	11.41%
EPS (Basic)	2.26	2.10	-1.15	-1.00	11.85	-2.87
EPS (Diluted)	2.20	2.06	-1.15	-1.00	11.85	-2.87
Free Cash Flow	268.78	238.5	-11.87	-29.49	-187.56	-211.26
Free Cash Flow Growth	12.70%	-	-	-	-	-
Free Cash Flow Per Share	5.18	4.63	-0.24	-0.53	-2.55	-3.04
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	1.23%	-3.35%	-72.92%	-97.58%	-179.09%	-466.06%
Profit Margin	1.43%	120.27%	-69.30%	-85.80%	-180.76%	-479.24%
FCF Margin	244.85%	221.93%	-18.43%	-51.35%	-365.29%	-381.96%
EBITDA	7.05	2.04	-40.83	-49.88	-84.25	-249.2
EBITDA Margin	6.42%	1.90%	-63.41%	-86.87%	-164.09%	-450.54%
EBIT	1.35	-3.6	-46.95	-56.04	-91.96	-257.78
EBIT Margin	1.23%	-3.35%	-72.92%	-97.58%	-179.09%	-466.06%
Effective Tax Rate	124.28%	0.00%	0.00%	0.00%	0.00%	0.06%

SEC Filings: 10-K · 10-Q